Insight into the relationship between disease burden at diagnosis and surgical resection on chemotherapy resistance and shorter progression free survival in epithelial ovarian, fallopian tube and primary peritoneal carcinoma in GOG 182

Hamilton, Chad

452
Insight into the relationship between disease burden at diagnosis and surgical resection on chemotherapy resistance and shorter progression free survival in epithelial ovarian, fallopian tube and primary peritoneal carcinoma in GOG 182

Sunday, March 29, 2015: 7:00 AM

Salon C-D (Hilton Chicago)

C. A. Hamilton¹, A. Miller², B. J. Rungruang³, S. D. Richard⁴, N. Rodriguez⁵, N. S. Horowitz⁶, G. L. Maxwell⁷ and T. C. Krivak⁸
¹Walter Reed National Military Medical Center, Bethesda, MD, ²Gynecologic Oncology Group, Buffalo, NY, ³Georgia Reagents University, Evans, GA, ⁴Hahnemann University Hospital/Drexel University College of Medicine, Philadelphia, PA, ⁵Southern California Permanente Medical Group, Irvine, CA, ⁶Harvard Medical School, Boston, MA, ⁷Inova Fairfax Hospital, Falls Church, VA, ⁸Western Pennsylvania Hospital, Pittsburgh, PA

2015 Annual Meeting on Women's Cancer®

March 26 - 31, 2015

Navigation

452
Insight into the relationship between disease burden at diagnosis and surgical resection on chemotherapy resistance and shorter progression free survival in epithelial ovarian, fallopian tube and primary peritoneal carcinoma in GOG 182

452 Insight into the relationship between disease burden at diagnosis and surgical resection on chemotherapy resistance and shorter progression free survival in epithelial ovarian, fallopian tube and primary peritoneal carcinoma in GOG 182

452
Insight into the relationship between disease burden at diagnosis and surgical resection on chemotherapy resistance and shorter progression free survival in epithelial ovarian, fallopian tube and primary peritoneal carcinoma in GOG 182